Serge Saxonov - Feb 22, 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Stock symbol
TXG
Transactions as of
Feb 22, 2023
Transactions value $
-$92,689
Form type
4
Date filed
2/24/2023, 04:51 PM
Previous filing
Dec 14, 2022
Next filing
Mar 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$92.7K -1.94K -0.21% $47.75 910K Feb 22, 2023 Direct F1
holding TXG Class A Common Stock 747 Feb 22, 2023 See footnote F2
holding TXG Class A Common Stock 146K Feb 22, 2023 See footnote F3
holding TXG Class A Common Stock 870 Feb 22, 2023 See footnote F4
holding TXG Class A Common Stock 9.4K Feb 22, 2023 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F5 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.